封面
市場調查報告書
商品編碼
1708914

脂肪醯胺市場按產品類型、形式和地區分類

Fatty Amides Market, By Product Type (Erucamide, Oleamide, Stearamide, Behenamide), By Form (Powder, Beads, Micro-beads, Pastilles), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球脂肪醯胺市場規模估計為 4.286 億美元,預計到 2032 年將達到 5.755 億美元,2025 年至 2032 年的複合年成長率為 4.3%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 4.286億美元
效能數據 2020-2024 預測期 2025-2032
預測期間:2025年至2032年的複合年成長率 4.30% 2032年價值預測 5.755億美元
數字。 2025年脂肪醯胺各地區市場佔有率(%)
脂肪醯胺市場-IMG1

近年來,由於脂肪醯胺在塑膠、橡膠和塗料等各種終端行業的應用不斷擴大,全球脂肪醯胺市場經歷了顯著成長。脂肪醯胺在這些行業中主要用作潤滑劑、流動增強劑和抗霜劑。脂肪醯胺具有熱穩定性好、耐化學性佳、液體範圍廣等優良性能。此外,來自可再生植物和動物的脂肪醯胺有助於減少對石油衍生產品的依賴,從而促進市場成長。然而,原物料價格波動仍然是一個重大挑戰。然而,隨著人們對生物基化學品的永續性和益處的認知不斷提高,脂肪醯胺製造商的機會也在不斷擴大。脂肪醯胺,通常稱為脂肪酸醯胺,是有機脂肪酸的衍生物,其中 OH 基團被 NH2(胺)基團取代。依產品類型,脂肪醯胺可分為Erucamide、油醯胺、硬脂醯胺和Behenamide。含有脂肪醯胺的產品以珠子、粉末狀、有時是錠劑的形式出售。

市場動態

全球脂肪醯胺市場的成長受到塑膠和橡膠工業成長以及生物基化學品的普及導致的需求增加等因素的推動。脂肪醯胺主要用作塑膠和橡膠混合中的潤滑劑、脫模劑和防黏劑。此外,對高性能產品的需求不斷成長,推動了脂肪醯胺的消費。然而,棕櫚油、椰子油、Tall oil原料的價格波動和供應不穩定帶來了重大挑戰。此外,有關石化產品排放的嚴格環境法規也抑制了市場的成長。同時,人們對永續性和生物化學品的偏好轉變也帶來了巨大的機會。領先的公司正在投資研發,以開發新的應用領域和環保生產技術。

研究的主要特點

  • 本報告對脂肪醯胺市場進行了詳細分析,並給出了預測期(2025-2032)的市場規模和年複合成長率(CAGR),假設 2024 年為基準年。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 脂肪醯胺市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 脂肪醯胺市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 個人護理行業的需求不斷成長
  • 替代產品的可用性
  • 脂肪族醯胺的創新,適用於利基市場
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 合併、收購和合作

4. 脂肪酸醯胺市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 脂肪醯胺市場(依產品類型),2020 年至 2032 年

  • 介紹
  • Erucamide
  • 硬脂醯胺
  • Behenamide
  • 油酸醯胺

6. 脂肪酸醯胺市場(依形態),2020 年至 2032 年

  • 介紹
  • 粉末和珠子
  • 微珠
  • 錠劑

7. 脂肪酸醯胺市場(依地區分類),2020-2032

第8章 競爭態勢

  • 公司簡介
    • Lonza
    • Novartis International AG
    • BASF AG
    • SEQENS
    • Carbogen Amcis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Bristol-Myers Squibb
    • Pfizer Inc.
    • Roche Diagnostics
    • Boehringer Ingelheim
    • Merck & Co
    • Bayer AG
    • Ajinomoto Bio-Pharma Services
    • Cambrex Corporation
    • Minakem
    • Sanofi Aventis

第9章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI3486

Global Fatty Amides Market is estimated to be valued at USD 428.6 Mn in 2025 and is expected to reach USD 575.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 428.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.30% 2032 Value Projection: USD 575.5 Mn
Figure. Fatty Amides Market Share (%), By Region 2025
Fatty Amides Market - IMG1

The global fatty amides market has been witnessing significant growth in recent years driven by growing applications in various end-use industries such as plastics, rubber, coatings, and others. Fatty amides are mainly used as lubricants, flow promoters, and anti-blooming agents in these industries. They offer excellent properties such as outstanding thermal stability, chemical resistance, and wide liquid range. Additionally, fatty amides derived from renewable plant and animal sources help reduce dependency on petroleum-based products, thereby boosting the market growth. However, fluctuations in raw material prices remain a key challenge. But growing awareness about sustainability and benefits of bio-based chemicals is expanding opportunities for fatty amides manufacturers. Fatty amides, often termed fatty acid amides, are derivatives of organic fatty acids where an OH group is replaced by an NH2 (amine) group. Depending on the type of product, fatty amides are differentiated as erucamides, oleamides, stearamides, and behenamides. Products containing fatty amides are available in beads, powders, and sometimes also the pastilles form.

Market Dynamics:

The growth of the global fatty amides market is driven by factors such as increasing the demand from the thriving plastics and rubber industries and widespread adoption of bio-based chemicals. Fatty amides find major applications as lubricants, release agents, and anti-blocking agents in plastics and rubber formulations. Additionally, the growing need for high-performance products is propelling the consumption of fatty amides. However, fluctuations in prices and unreliable supply of raw materials such as palm oil, coconut oil, and tall oil pose a major challenge. Furthermore, strict environmental regulations regarding emissions from petrochemical-based products restrain the market growth. Meanwhile, shifting preference toward sustainability and bio-based chemicals presents significant opportunities. Leading players are investing in R&D to develop novel application areas and green production technologies.

Key Features of the Study:

  • This report provides an in-depth analysis of the fatty amides market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the fatty amides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Haihang Industries Co. Ltd., Croda International Plc., PMC Biogenix Inc., Fine Organic Industries Pvt. Ltd., Nippon Fine Chemicals Co., Ltd., Kao Corporation, Italmatch Chemicals S.p.A., Sichuan Tianyu Oleochemical Co., Ltd., and Nippon Kasei Chemical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The fatty amides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

  • Fatty Amides Market, By Product Type
    • Erucamides
    • Oleamides
    • Stearamides
    • Behenamides
  • Fatty Amides Market, By Form
    • Powder, Beads
    • Micro-beads
    • Pastilles
  • Fatty Amides Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Haihang Industries Co. Ltd.
    • Croda International Plc.
    • PMC Biogenix Inc.
    • Fine Organic Industries Pvt. Ltd.
    • Nippon Fine Chemicals Co., Ltd.
    • Kao Corporation
    • Italmatch Chemicals S.p.A.
    • Sichuan Tianyu Oleochemical Co., Ltd.
    • Nippon Kasei Chemical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Fatty Amides Market, By Product Type
    • Fatty Amides Market, By Form
    • Fatty Amides Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand from the personal care industry
    • Restraints
  • Availability of substitutes
    • Opportunities
  • Innovation of fatty amides for niche Forms
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Fatty Amides Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Fatty Amides Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Erucamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Stearamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Behenamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Oleamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Fatty Amides Market, By Form , 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Powder, Beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Micro-beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pastilles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Fatty Amides Market , By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
        • South Africa
        • Central Africa
        • North Africa

8. Competitive Landscape

  • Company Profile
    • Lonza
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis International AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • BASF AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • SEQENS
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Carbogen Amcis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Roche Diagnostics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ajinomoto Bio-Pharma Services
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Cambrex Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Minakem
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi Aventis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
      • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us